Skip to content
Research Article Open access CC BY 3.0

Seroincidence of Human Herpes Virus 2 Among Ante-natal Clinic Attendees in Benin, Nigeria

E. I. Kalu, K. Akubuo, F. E. Agwu, E. O. Yusuf, C. K. Ojide, V. U. Nwadike

International Journal of TROPICAL DISEASE & Health · pp. 330–343 · Published 15 Jan 2014

10.9734/IJTDH/2014/7020

Abstract

Background: Human Herpes Virus 2 (HSV-2) infection has been shown to be significantly associated with several obstetric complications, especially if the infection occurred during the pregnancy. Advocacy for policy formulation and the design of interventions requires local data on the risk factors for incident HSV-2 infection. The aim of this study is to assess HSV-2 sero-incidence among pregnant women in Benin and the effect of socio-demographic factors, HIV status, and HSV-1 status. Study Location, Design and Duration: Pregnant women attending ante-natal clinic in University of Benin Teaching Hospital and Central Hospital, Benin were prospectively recruited. A cross-sectional study was done and baseline data, obtained. The HSV-2 seronegative participants were followed up till the last clinic appointments [the closest appointment to their expected delivery dates (EDD)]. The study took place between November 2011 and December 2012. Methods: On recruitment a structured self-administered questionnaire was used to capture their socio-demographic data. Obstetric data was obtained from the patients’ case notes. Their HSV-1 and HSV-2 serostatuses were determined using an HSV glycoprotein G-based type-specific ELISA technique. Their HIV statuses were also determined. All those who were seronegative for HSV-2 were retested for HSV-2 six months later and/or on their last clinic appointment before the EDD. Incidence rates were calculated per person-years. Data analysis utilized SPSS version 16 software. Results: Out of the 674 participants, 315(46.8%) were HSV-2 seropositive while 359 (53.2%) were seronegative. 15.9% (57) of the HSV-2 sero-negative ones were lost to follow-up, giving a response rate of 84.1%. Seroincidence rate was found to be 17.9 per 100 person-years. There was significant association of seroincidence with younger reproductive age groups, unmarried status, and education below secondary level. Relative Risk (RR) and Incidence rate ratio (IRR) of HSV-2 infection among the HIV-infected cohort were 55.15 [95%CI:17.0-179.1] and 72.37 [95% CI:71.11-73.63] respectively. The RR and IRR among the HSV-1-seronegative cohort were 1.43 [95%CI:0.64-3.17] and 11.62 [95%CI:9.60-13.64] respectively. Conclusion: Seroincidence rate of HSV-2 infection among pregnant women in Benin was found to be 17.9 per 100 person-years. Positive HIV status, young age, unmarried status, and low education level were indicators of increased risk of incident HSV-2 infection.

Seroprevalence seroincidence HSV-2 HSV-1 HIV risk factors incidence rate ratio

References (22)

  1. 1 Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review [DOI]
  2. 2 Risk of Human Immunodeficiency Virus Infection in Herpes Simplex Virus Type 2–Seropositive Persons: A Meta‐analysis [DOI]
  3. 3 A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2 [DOI]
  4. 4 An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection [DOI]
  5. 5 Effect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania [DOI]
  6. 6 Human Immunodeficiency Virus Infection and Genital Ulcer Disease in South Africa [DOI]
  7. 7 Human Immunodeficiency Virus Acquisition Associated with Genital Ulcer Disease and Herpes Simplex Virus Type 2 Infection: A Nested Case‐Control Study in Rakai, Uganda [DOI]
  8. 8 Time Course of Seroconversion by HerpeSelect ELISA After Acquisition of Genital Herpes Simplex Virus Type 1 (HSV-1) or HSV-2 [DOI]
  9. 9 Oxford Handbook of Infectious Diseases and Microbiology [DOI]
  10. 10 A prospective study of risk factors for herpes simplex virus type 2 acquisition among high-risk HIV-1 seronegative women in Kenya [DOI]
  11. 11 The Epidemiology of HIV and HSV-2 Infections among Women Participating in Microbicide and Vaccine Feasibility Studies in Northern Tanzania [DOI]
  12. 12 Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. [DOI]
  13. 13 Risk Factors for Incident Herpes Simplex Type 2 Virus Infection Among Women Attending a Sexually Transmitted Disease Clinic [DOI]
  14. 14 Herpes Simplex Viruses and Herpes B Virus [DOI]
  15. 15 Avidity of Antibodies against HSV-2 and Risk to Neonatal Transmission among Mexican Pregnant Women [DOI]
  16. 16 Seroprevalence and co-infection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria.
  17. 17 Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic [DOI]
  18. 18 Herpesvirus hominis antibodies among children and young adults in Ibadan. [DOI]
  19. 19 Seroprevalence and Seroincidence of Herpes Simplex Virus Type 1 and Herpes Simplex Virus Type 2 Infections in a Cohort of Adolescents in Italy [DOI]
  20. 20 Congenital Infections [DOI]
  21. 21 Herpes Simplex Virus Virion Host Shutoff Protein Requires a Mammalian Factor for Efficient In Vitro Endoribonuclease Activity [DOI]
  22. 22 Herpes Simplex Viruses and Herpes B Virus [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

45

Page views

0

PDF downloads

4

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.